Cargando…

Relationship between the use of polymyxin B-immobilized fiber for hemofiltration and some laboratory parameters (endocannabinoids, high mobility group box-1 protein and oxidative stress) in severe pneumonia patients

Detalles Bibliográficos
Autores principales:	Mashiko, K, Sakamoto, Y, Obata, T, Matsumoto, H, Hara, Y, Kutsukata, N, Yamamoto, Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088827/ http://dx.doi.org/10.1186/cc6677

Ejemplares similares

Increase in systolic blood pressure and improvement in laboratory parameters following polymyxin B-immobilized fiber treatment in septic shock
por: Sakamoto, Y, et al.
Publicado: (2010)

Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients
por: Sakamoto, Y, et al.
Publicado: (2006)

Effectiveness of early start of direct hemoperfusion with polymyxin B-immobilized fiber columns judging from stabilization in circulatory dynamics in surgical treatment patients
por: Sakamoto, Yuichiro, et al.
Publicado: (2010)

Removing endocannabinoids and reducing oxidative stress with polymyxin-B-immobilized fibers in patients with septic shock
por: Kase, Y, et al.
Publicado: (2007)

Mechanism and effectiveness of polymyxin B-immobilized fiber columns for removing mediators (HMBG-1, 2-arachidonoyl glycerol, anandamide, PAI-1, protein C and IL-6) in septic shock patients
por: Sakamoto, Y, et al.
Publicado: (2007)

Relationship between the presence of serum high-mobility-group box protein 1 and the injury severity score in trauma patients
por: Sakamoto, Y, et al.
Publicado: (2007)

Observational study for direct hemoperfusion therapy with polymyxin-B immobilized fibers (PMX-DHP) in patients with septic shock in Japan: PMX-DHP study group
por: Kase, Y, et al.
Publicado: (2009)

Best choice of acute blood purification therapy based on the severity score and blood lactic acid values in septic shock patients
por: Sakamoto, Y, et al.
Publicado: (2009)

Examination of the utility of serum lactate and base deficit in hemorrhagic shock
por: Jonishi, K, et al.
Publicado: (2010)

Anti-endotoxin Properties of Polymyxin B-immobilized Fibers
por: Tani, Tohru, et al.
Publicado: (2019)

Serum high-mobility group box-1 protein as a specific marker of severe abdominal injury
por: Sakamoto, Y, et al.
Publicado: (2009)

Apheresis of activated leukocytes with an immobilized polymyxin B filter
por: Takeyama, N, et al.
Publicado: (2010)

Effectiveness of continuous venovenous hemodiafiltration using a polymethylmethacrylate membrane hemofilter in septic shock patients
por: Sakamoto, Y, et al.
Publicado: (2008)

Polymyxin B-immobilized fiber column hemoperfusion has the ability of endotoxin removal during 24 hours
por: Mitaka, C, et al.
Publicado: (2012)

Clinical efficacy of long-term performance with polymyxin-B immobilized fiber treatment for septic shock
por: Matumoto, N, et al.
Publicado: (2008)

Polymyxin B-immobilized fiber hemoperfusion therapy improves sepsis-related immunosuppression
por: Kimura, A, et al.
Publicado: (2014)

Effectiveness of continuous venovenous hemodiafiltration using a polymethylmethacrylate membrane hemofilter judging from a multiplex suspension array system in septic shock patients
por: Sakamoto, Y, et al.
Publicado: (2011)

Selection of acute blood purification therapy according to severity score and blood lactic acid value in patients with septic shock
por: Sakamoto, Yuichiro, et al.
Publicado: (2010)

Extended duration of direct hemoperfusion with polymyxin B-immobilized fiber column improves hemodynamics in patients with septic shock
por: Yamashita, C, et al.
Publicado: (2011)

High mobility group box 1 levels in septic disseminated intravascular coagulation patients undergoing Polymixin-B immobilized fiber-direct hemoperfusion
por: Ishibe, Y, et al.
Publicado: (2012)

Effectiveness of Human Atrial Natriuretic Peptide Supplementation in Pulmonary Edema Patients Using the Pulse Contour Cardiac Output System
por: Sakamoto, Yuichiro, et al.
Publicado: (2010)

Effectiveness of polymyxin b immobilized fiber hemoperfusion in patients with septic shock due to Gram-negative bacillus infection: the PMXHP study
por: Saito, N, et al.
Publicado: (2015)

Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review
por: Cruz, Dinna N, et al.
Publicado: (2007)

Successful Recovery from COVID-19-associated Acute Respiratory Failure with Polymyxin B-immobilized Fiber Column-direct Hemoperfusion
por: Kusaba, Yusaku, et al.
Publicado: (2020)

Efficacy of direct hemoperfusion with a polymyxin B‐immobilized fiber column in miliary tuberculosis
por: Kawano, Yasumasa, et al.
Publicado: (2016)

Impact of hemoperfusion with polymyxin B added to hemofiltration in patients with endotoxic shock: a case–control study
por: Navas, Ana, et al.
Publicado: (2018)

Efficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection
por: Saito, Nobuyuki, et al.
Publicado: (2017)

Survival from an Acute Exacerbation of Idiopathic Pulmonary Fibrosis with or without Direct Hemoperfusion with a Polymyxin B-immobilized Fiber Column: A Retrospective Analysis
por: Oishi, Keiji, et al.
Publicado: (2016)

Prognostic factors in patients with septic shock in digestive surgery who have undergone direct hemoperfusion with polymyxin B-immobilized fibers: a retrospective observational study
por: Matsukuma, Satoshi, et al.
Publicado: (2015)

Re-evaluation of direct hemoperfusion with polymyxin-B immobilized fiber for severe sepsis and septic shock
por: Matsuo, SM, et al.
Publicado: (2011)

Suggestions and tips regarding polymyxin B-immobilized fiber column direct hemoperfusion of neonates with sepsis
por: Nishizaki, Naoto
Publicado: (2020)

Therapeutic Rationale for Endotoxin Removal with Polymyxin B Immobilized Fiber Column (PMX) for Septic Shock
por: Shoji, Hisataka, et al.
Publicado: (2021)

Up-to-date information on polymyxin B-immobilized fiber column direct hemoperfusion for septic shock
por: Mitaka, Chieko, et al.
Publicado: (2021)

Beneficial effects of early hemoperfusion with a polymyxin B fibre column on septic shock
por: Takeyama, N, et al.
Publicado: (2009)

In vitro evaluation of HMGB1 removal with various membranes for continuous hemofiltration
por: Yumoto, M, et al.
Publicado: (2011)

Investigation of type II phospholipase A(2 )values and eicosanoid values during polymyxin-B-immobilized fiber direct hemoperfusion of septic shock patients
por: Shouzushima, T, et al.
Publicado: (2009)

A Case of Polymyxin b-Immobilized Fiber Column Treatment for Rapidly Progressive Interstitial Pneumonia Associated with Clinically Amyopathic Dermatomyositis
por: Sasaki, Oh, et al.
Publicado: (2013)

Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation
por: Kushi, Hidehiko, et al.
Publicado: (2005)

Hemoperfusion with an immobilized polymyxin B fiber column improves gastric mucosal pH with sepsis patients
por: Kushi, H, et al.
Publicado: (2006)

History and current status of polymyxin B‐immobilized fiber column for treatment of severe sepsis and septic shock
por: Shimizu, Tomoharu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e038j9mg4cd8ckqnsscv9h0k4n